Litigation Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
✉ Email this page to a colleague
GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-07-03 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:145 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | Plaintiff | Referred To | Judge Christopher J. Burke |
Patents | RE40 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA
Details for GlaxoSmithKline LLC v. Glenmark Pharmaceuticals Inc., USA (D. Del. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-04-12 | 110 | Amended Infringement Contentions for U.S. Patent No. RE40,000 Against Defendant Glenmark Pharmaceuticals… 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
2016-06-03 | 133 | indirectly infringe U.S. Patent No. RE40,000 (the "'000 patent"). Presently before the…assignment, of the '000 patent, and GlaxoSmithKline LLC is the patent's exclusive licensee. (Id…, ex. B) Citation to the patent will simply be to the "'000 patent." … '000 Patent In June 1995, GSK and its research partner filed a patent application directed…CHF, which issued as U.S. Patent No. 5,760,069 (the '"069 patent") entitled "Method | External link to document | |
2016-09-19 | 159 | ., M.P.H. Regarding Infringement of U.S. Patent No. RE40,000 by Glenmark Pharmaceuticals, Inc. USA; (3… 3 July 2014 1:14-cv-00877-LPS-CJB Patent Plaintiff District Court, D. | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |